author-photo

E. Capomolla

14

Papers

76

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial

2021 International Journal of Medical Sciences
Show All
- Source
- Cite
- Save
Citations (2)
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study

2021 Biomarker research
Show All
- Source
- Cite
- Save
Citations (2)
Surgical Site Infections in Breast Cancer Patients Undergoing Surgery During the Covid-19 Pandemic. Preliminary Data from an Italian Oncologic Hub.

2021
Show All
- Source
- Cite
- Save
Citations (0)
The Political Drivers of the Sovereign Bond Yield Spreads: Evidence from the Euro Area

2020
- E. Capomolla
Show All
- Source
- Cite
- Save
Citations (0)
High Activity of Salvage Treatment with Biweekly Paclitaxel- Gemcitabine Combination in Heavily Pretreated Breast Cancer Patients

2006 Journal of Experimental & Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (11)
P-538 Sequential treatment with docetaxel-cisplatin (DP) doublet allows higher conversion to response for patients (pts) with advanced NSCLC in stable disease (SD) after 2 courses of gemcitabine-cisplatin (GP): Preliminary results of a pilot study

2005 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Early switch to a docetaxel-cisplatin (DP) doublet allows higher conversion to response for patients (pts) with advanced NSCLC in stable disease (SD) after 2 courses of gemcitabine-cisplatin (GP): Preliminary results of a pilot study

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PACLITAXEL ACTIVITY IN ANTHRACYCLINE REFRACTORY BREAST CANCER PATIENTS

1997 Tumori
Show All
- Source
- Cite
- Save
Citations (9)
102 P - CEF ± G-CSF As primary chemotherapy (PCT) in ≥ 3cm breast cancer (BC) patients(PTS)

1996 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a

1995 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (37)